跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAYVIGO - SFDA Drug Approval Details
Approvals
/
SFDA
/
DAYVIGO
Authorized
NCE
DAYVIGO
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
6477c337244e83a2
Company
Unknown
Type
NCE
Approval Details
Approval Id
6477c337244e83a2
Drug Approval Sfda Name
DAYVIGO
Trade Name
DAYVIGO
Generic Name
LEMBOREXANT
Register Number
2101256710
Register Year
2025
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Blister
Package Size
28
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
60 Months
Distribution Site
Pharmacy
Description Code
7000002770-5-100000073665
Price
219.6
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
6477c337244e83a2
Type
NCE
Back to SFDA Approvals